Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Data presented at SABCS indicates benefits of oral paclitaxel and encequidar (oral paclitaxel) versus IV paclitaxel (IVP) on Progression-Free Survival (PFS) and on Overall Survival (OS), which...
-
Dublin, Dec. 09, 2020 (GLOBE NEWSWIRE) -- The "The U.S. Market for Urgent Care Centers (Including COVID-19, POC Tests, Vaccines and Other Sales)" report has been added to ResearchAndMarkets.com's...
-
Presentations highlight lumateperone’s broad antidepressant effects in patients with bipolar disorder and in patients with schizophrenia with co-morbid depression NEW YORK, Dec. 09, 2020 (GLOBE...
-
Final rules establish, for the first time, a Category 1 CPT code and reimbursement to physicians performing ablation of malignant prostate tissue with HIFU in the USPhysician reimbursement for...
-
-- EXPAREL average daily sales at 103% of the prior year for the month of November 2020 -- PARSIPPANY, N.J., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the...
-
Featuring Global Experts in Ayurveda and PharmacologyDecember 16, 2020 7 AM PST- 10 AM EST- 8:30 PM ISTPanel Discussion and Q & A to follow Agoura Hills, California, Dec. 09, 2020 (GLOBE...
-
Third Quarter Net Sales Growth of 43.5%; Comparable Sales Growth of 53.5%Net Income Increases to $2.5 million from ($6.7) million in Third Quarter Fiscal 2021Adjusted EBITDA Increases to $6.0 million...
-
--Transformation to Premium Oncology Biopharmaceutical Company with Late-Stage Clinical Drug Pipeline Focused on Prostate and Breast Cancer is Complete-- --Company Poised to Initiate Four...
-
—FY20 Full-Year Net Revenues and Gross Profit Achieve Historical Highs of $43 Million and $31 Million, Respectively— —Robust Growing Prescription Sales of FC2 Key Growth Driver; Product...
-
SHANGHAI, China, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that...